Reuters logo
BRIEF-Atara Biotherapeutics receives FDA orphan drug designation for ATA230
2017年9月5日 / 中午12点13分 / 21 天前

BRIEF-Atara Biotherapeutics receives FDA orphan drug designation for ATA230

Sept 5 (Reuters) - Atara Biotherapeutics Inc:

* Atara Biotherapeutics receives FDA orphan drug designation for ata230

* Atara Biotherapeutics - ATA230 granted orphan drug designation for treatment of cytomegalovirus viremia & disease in immunocompromised patients by​ FDA Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below